Short answer
ABEONA THERAPEUTICS INC. (ABEO) filed an 8-K current report with the SEC on March 17, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Q1 2025 earnings results disclosed via press release exhibit: refer to Exhibit 99.1 for actual financial figures.
ABEONA THERAPEUTICS INC. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q1 2025 earnings results disclosed via press release exhibit: refer to Exhibit 99.1 for actual financial figures
- Filing structured to limit legal liability under Exchange Act Section 18: standard earnings release protective language
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other ABEONA THERAPEUTICS INC. 8-K filings
Get the next ABEO 8-K as it lands
Follow ABEO for push alerts, or ask the research agent what this filing means.